
Australia's Driving Force for Pure Performance in Sport
Deterrence · Detection · Enforcement
Finasteride (marketed as Proscar, Propecia, Fincar, Finpecia, Finax, Finast, Finara, Finalo, Prosteride, Gefina, Finasterid IVAX) is an anti-androgen which acts by inhibiting type II 5-alpha reductase, the enzyme that converts testosterone to dihydrotestosterone (DHT). It is registered in many countries for androgenetic alopecia (male-pattern baldness). It can also be used as a treatment in benign prostatic hyperplasia in low doses, and prostate cancer in higher doses.
Finasteride has been linked to following side effects:
Finasteride is a prohibited substance in and out of competition as it is a potential masking agent for androgenic steroids.
Before using any prohibited substances, athletes must contact their NSO to determine whether their sport's anti-doping rules allow for standard Therapeutic Use Exemptions (TUEs). If the NSO allows the therapeutic use of prohibited substances, the athlete must strictly adhere to the approval procedures. More information on standard TUEs and access to standard TUE application forms can be found on the ASADA website and the Australian Sports Drug Medical Advisory Committee (ASDMAC) website www.asdmac.org.au.
For further information about the status of any substance in sport please go to the ASADA website www.asada.gov.au or contact the ASADA Hotline on 1800 020 506.
» Information available for download
[ PDF 78 Kb ]
NOTE: You will need Adobe Reader in order to view PDF files.
To download Adobe Reader go to http://www.adobe.com/products/acrobat/readstep.html.
This page last updated Tuesday, January 22, 2008
Copyright © 2008, Australian Sports Anti-Doping Authority (ASADA)